← Back to all signals
RESEARCH PAPER ANALYSIS

Evaluating the consequences of critically ill patients with pediatric cancer at Aliasghar Children's Hospital.

AI interpretation is pending for this paper.

Open original publication →
PMID39228541
JournalJournal of family medicine and primary care
Publication Date2024-07-26
Ingested2026-08-02 12:02 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Despite significant progress in supportive care and advancements in chemotherapy treatments, cancer remains a leading cause of mortality in children. The objective of this study was to assess the potential correlation between various risk factors and the consequences of patients with pediatric cancer who were admitted to the pediatric intensive care unit (PICU). METHODS: The present investigation is a retrospective cohort study that examined children with cancer who were between the ages of 1 month and 17 years and had been admitted to the PICU. Demographic and clinical information of all patients, including such as the age, type of cancer, sex, BMI, history of specific disease, PICU admission time, disease condition on PICU admission, patient's status at PICU admission, and number of organ failures, were extracted from each patient file. RESULTS: The number of pediatric oncology patients admitted to the PICU was 127. The highest mortality rate was observed among children with heart problems (75%), followed by CNS involvement (54.2%) and sepsis (42.9%). The study found that various factors had a significant effect on the outcomes of patients who were admitted to the PICU, including but not limited to the primary type of malignancy, disease status, indications for hospital admission, patient's condition, inpatients' length of stay (LOS), tumor type, and the extent of organ failure at the time of admission to the PICU. CONCLUSION: Despite recent advancements in healthcare, the prognosis of patients admitted to the PICU in underdeveloped areas remains suboptimal in comparison to those in developed regions. Poor outcomes were found to be significantly associated with various factors, including the primary type of malignancy, disease status, the reason for admission to the PICU, patient's condition, LOS, tumor type, and the extent of organ failure, especially in cases involving hematological malignancies.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Not Just a Pediatric Condition: Down Syndrome Across the Lifespan. Missouri medicine 54.0 2 The incidence of thyroid cancer in Danish children, adolescents and young adults. Danish medical journal 56.0 3 Cancer in Young Women: Late-Stage Breast Cancer Registry Analysis of a 24-Year Nationwide Retrospective Cohort of 52,734 Patients in Brazil (CLARA Study). Clinical breast cancer 71.0 4 Pediatric Familial Cerebral Cavernous Malformation Associated With a Novel KRIT1 Initiation-Region Frameshift Variant. Molecular genetics & genomic medicine 56.0 5 Social Inequalities, Geographical Accessibility to Care, and Excess Mortality for Patients With Hematological Malignancies in France: Results From French Cancer Registries. Hematological oncology 65.2 6 Bibliometric and clinical trial landscape of hepatoblastoma (2000-2024): a multi-database analysis of global research. Frontiers in oncology 77.1 7 Treatment and outcomes of hepatoblastoma in a tertiary care pediatric institution: a single-center experience. Frontiers in oncology 69.54 8 Letermovir for cytomegalovirus prophylaxis after allogeneic hematopoietic stem cell transplantation in acute leukemia patients: results of the LETreal study. Frontiers in immunology 63.7 9 Emotional regulation and music engagement: a meta-analytic synthesis. Frontiers in psychology 82.8 10 Adult Wilms tumor revealed after radical nephrectomy for a renal mass initially suspected to be clear-cell renal cell carcinoma: a case report. Frontiers in surgery 53.5 11 Transcatheter embolization as a rescue therapy for refractory pelvic kaposiform hemangioendothelioma with Kasabachi-Merritt phenomenon: a case report. Frontiers in pediatrics 55.16 12 Parenting concerns among patients with cancer: a qualitative meta-synthesis. Frontiers in psychology 71.5 13 Clinical trial design for primary brain tumors: a problem-based framework for neuro-oncology practice. Frontiers in oncology 76.8 14 Risk of malignancy and surveillance of premalignant gastrointestinal lesions in adult celiac disease. Frontiers in oncology 56.0 15 Incidental findings on preoperative computed tomography for the planning of robotic arthroplasty: retrospective cohort study. BJS open 68.5 16 Trends in Helicobacter pylori prevalence, force of infection, and attributable disease burden in China: a systematic review and Bayesian modelling study. The Lancet regional health. Western Pacific 71.5 17 Paediatric Primary Intracranial Tumours: A 14-year Clinicopathologic Study in North-Central Nigeria. Nigerian medical journal : journal of the Nigeria Medical Association 57.5 18 Testicular Schistosomiasis Mimicking Testicular Tumour: A Case Report. Nigerian medical journal : journal of the Nigeria Medical Association 45.5 19 The Impact of Enteral Nutritional Support on Surgical Complications and Clinical Efficacy in Children With Neuroblastoma With Moderate or High Nutritional Risk. Annali italiani di chirurgia 76.0 20 Culture-Proven Haemophilus influenzae Endophthalmitis After Intravitreal Topotecan for Retinoblastoma. Journal of vitreoretinal diseases 60.4 21 Identification of Antileukemic Compound From Ginger by Integrating UHPLC-MS, Network Pharmacology, Molecular Docking, Molecular Dynamics Simulation, and In Vitro and In Vivo Experimental Validation. Food science & nutrition 58.8 22 Levetiracetam therapeutically targets GABAergic synapses in diffuse midline glioma. Nature medicine 55.54 23 Inaccessible mental health care is a risk factor for risky drinking behaviors among cancer survivors: an All of Us survey-based cohort study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 65.5 24 Editorial for "Deep Learning Pipeline for Automatic Segmentation, Classification, and Molecular Subtyping of Three Pediatric Posterior Fossa Tumors Using T2-Weighted MRI". Journal of magnetic resonance imaging : JMRI 47.5 25 Pediatric Superficial Malignant Perineurioma/Perineuriomatous Malignant Peripheral Nerve Sheath Tumor of the Groin With NF1 Loss: A Case Report and Focused Review of the Literature. Journal of cutaneous pathology 47.5 26 Identification of favorable subgroups of pediatric high-hyperdiploid acute lymphoblastic leukemia-A retrospective multinational study. HemaSphere 47.5 27 Epidemiology and treatment outcomes of bone and soft tissue sarcoma in pediatric and adolescent and young adult patients in Japan: data from population-based National Cancer Registry 2016-2019. Cancer investigation 74.34 28 Therapy-Associated Lineage Switch and Clonal Evolution in Refractory NUP98::NSD1-Rearranged Acute Leukemia. Pediatric blood & cancer 33.36 29 Ileocecal Paracoccidioidomycosis Presenting as a Pseudotumoral Lesion in a Pediatric Patient: A Histopathological Diagnostic Challenge. International journal of surgical pathology 56.0 30 Clinical Diagnostic Challenges in Childhood Pilomatrixoma: A Retrospective Study of 74 Patients. The Journal of craniofacial surgery 66.0 31 Female Cardiovascular Health After Childhood Cancer. Current cardiology reports 59.4 32 Major mental disorders in offspring of mothers with polycystic ovary syndrome. Archives of women's mental health 37.0
PATIENT-FRIENDLY SUMMARY

Evaluating the consequences of critically ill patients with pediatric cancer at Aliasghar Children's Hospital.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic